Oragenics, Inc. (OGEN)
NYSEAMERICAN: OGEN · Real-Time Price · USD
0.961
+0.061 (6.79%)
Mar 9, 2026, 3:18 PM EDT - Market open
Oragenics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 4 | 5 | 14 | 12 | 52 | 41 | |
| Market Cap Growth | 17.11% | -68.80% | 16.96% | -76.19% | 25.99% | 78.59% | |
| Enterprise Value | -7 | 3 | 11 | 1 | 26 | 40 | |
| Last Close Price | 0.90 | 11.08 | 168.81 | 189.20 | 802.88 | 808.28 | |
| PS Ratio | - | - | 383.93 | 93.97 | 596.78 | - | |
| PB Ratio | 0.38 | -21.29 | 4.56 | 0.95 | 1.96 | 2.45 | |
| P/TBV Ratio | 0.39 | - | 9.18 | 1.08 | 2.18 | 4.26 | |
| EV/Sales Ratio | - | - | 286.83 | 6.33 | 294.77 | - | |
| Debt / Equity Ratio | 0.04 | -1.55 | 0.10 | 0.05 | 0.03 | 0.05 | |
| Net Debt / Equity Ratio | -1.12 | 2.53 | -1.00 | -0.83 | -1.00 | -0.99 | |
| Net Debt / EBITDA Ratio | - | 0.05 | 0.15 | 0.75 | 1.68 | 0.63 | |
| Net Debt / FCF Ratio | 1.31 | 0.06 | 0.43 | 0.71 | 1.96 | 0.99 | |
| Asset Turnover | - | - | 0.00 | 0.01 | 0.00 | - | |
| Quick Ratio | 3.97 | 0.51 | 1.94 | 7.17 | 18.87 | 13.14 | |
| Current Ratio | 4.42 | 0.87 | 2.15 | 8.95 | 19.17 | 13.40 | |
| Return on Equity (ROE) | -168.95% | -714.95% | -255.36% | -72.35% | -72.52% | -155.13% | |
| Return on Assets (ROA) | -71.33% | -204.98% | -132.48% | -41.93% | -42.03% | -86.66% | |
| Return on Capital Employed (ROCE) | -103.90% | 4983.30% | -659.80% | -109.60% | -58.90% | -153.70% | |
| Earnings Yield | -284.11% | -234.31% | -142.89% | -115.61% | -30.27% | -64.15% | |
| FCF Yield | -219.61% | -190.62% | -50.43% | -124.24% | -26.03% | -41.14% | |
| Buyback Yield / Dilution | -1588.05% | -194.35% | -11.97% | -3.40% | -106.24% | -33.69% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.